Literature DB >> 11123843

New statins and new doses of older statins.

E A Stein1.   

Abstract

The need for greater reductions in LDL cholesterol, although remaining to be proven as clinically beneficial, continues to drive the development of either higher doses of currently approved and marketed statins or the development of new, more effective agents.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11123843     DOI： 10.1007/s11883-001-0005-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  5 in total

1.  The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1997-07-01       Impact factor: 2.778

2.  Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia.

Authors:  E Stein; J Isaacsohn; R Stoltz; A Mazzu; M C Liu; C Lane; A H Heller
Journal:  Am J Cardiol       Date:  1999-05-15       Impact factor: 2.778

3.  Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.

Authors:  W Insull; J Isaacsohn; P Kwiterovich; P Ra; R Brazg; C Dujovne; M Shan; E Shugrue-Crowley; S Ripa; R Tota
Journal:  J Int Med Res       Date:  2000 Mar-Apr       Impact factor: 1.671

4.  A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH).

Authors:  M MacMahon; C Kirkpatrick; C E Cummings; A Clayton; P J Robinson; R H Tomiak; M Liu; D Kush; J Tobert
Journal:  Nutr Metab Cardiovasc Dis       Date:  2000-08       Impact factor: 4.222

5.  The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day.

Authors:  M H Davidson; E A Stein; C A Dujovne; D B Hunninghake; S R Weiss; R H Knopp; D R Illingworth; Y B Mitchel; M R Melino; R V Zupkis; M R Dobrinska; R D Amin; J A Tobert
Journal:  Am J Cardiol       Date:  1997-01-01       Impact factor: 2.778
  5 in total
  1 in total

Review 1.  Combination lipid-lowering therapy in diabetes.

Authors:  Michael H Davidson
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.